```html

Skin Eczema – A Comprehensive Medical Guide

Overview

Eczema, medically known as atopic dermatitis, is a chronic inflammatory skin condition characterized by dry, itchy, and often red patches. It is the most common form of eczema, but the term also includes other sub‑types such as contact dermatitis, dyshidrotic eczema, and nummular eczema.

**Who it affects** – Eczema can appear at any age, but it most often begins in childhood. Approximately 10‑20 % of children and 1‑3 % of adults worldwide are affected <sup>1</sup>. Females slightly out‑number males in adulthood, and people of Asian descent have a higher prevalence of certain sub‑types (e.g., flexural eczema). The condition tends to run in families, suggesting a strong genetic component.

**Prevalence** – In the United States, the CDC estimates that about 13 % of children under 18 have eczema, making it the fourth most common chronic condition in this age group <sup>2</sup>. Globally, the International Study of Asthma and Allergies in Childhood (ISAAC) reports prevalence rates ranging from 2 % in some African nations to more than 20 % in Western Europe and North America.

Symptoms

Eczema symptoms can vary by age, skin type, and eczema subtype. Common features include:

• Itching (pruritus) – Often intense, especially at night.
• Dry, scaly skin – A “rough” texture that may crack.
• Redness (erythema) – Usually in the creases of elbows, knees, and neck, but can affect any area.
• Swelling – Particularly during acute flare‑ups.
• Blisters or vesicles – Small fluid‑filled bumps that may ooze.
• Thickened skin (lichenification) – Result of chronic scratching, leading to leathery plaques.
• Crusting or oozing – Wet lesions that dry to a yellowish crust.
• Hyperpigmentation – Darker patches after inflammation resolves, more common in people with darker skin tones.
• Location‑specific signs:
  • Infants: Facial cheeks, scalp, and extensor surfaces.
  • Children: Elbows, behind knees, wrists, and the neck.
  • Adults: Hands, eyelids, and the neckline.

Causes and Risk Factors

Underlying causes

Eczema is multifactorial, involving a combination of genetic, immunologic, and environmental factors.

• Genetic predisposition – Mutations in the FLG gene (filaggrin) impair the skin barrier, allowing water loss and irritant penetration.
• Immune system dysregulation – Over‑activation of Th2‑type immune pathways leads to increased cytokines (IL‑4, IL‑13) that promote inflammation.
• Environmental triggers – Harsh soaps, detergents, wool, temperature extremes, and low humidity.
• Allergens – Dust mites, pet dander, pollen, and certain foods (egg, milk, peanuts) can exacerbate symptoms, especially in children.
• Microbial colonization – Staphylococcus aureus colonization is found on the skin of up to 90 % of patients with active eczema and can worsen inflammation.
• Stress – Psychological stress can amplify itch and flare‑ups via neuro‑immune pathways.

Risk factors

• Family history of eczema, asthma, or allergic rhinitis (the “atopic triad”).
• Living in urban or industrialized areas with higher pollution levels.
• Early exposure to harsh skin cleansers or frequent bathing with hot water.
• Presence of other skin conditions (e.g., psoriasis) that compromise barrier function.
• Age – first year of life is the peak onset period.

Diagnosis

Diagnosis is primarily clinical, based on history and physical examination. No single laboratory test confirms eczema, but the following may be used to support the diagnosis or rule out other conditions:

• History and visual assessment – The Hanifin‑Rajka criteria (four major and three minor features) are widely used.
• Patch testing – Identifies contact allergens when allergic contact dermatitis is suspected.
• Skin scrapings or swabs – To detect bacterial colonization (e.g., S. aureus) or fungal infection.
• Blood tests – Elevated serum IgE and eosinophil counts may be present but are not diagnostic.
• Skin biopsy – Rarely needed; performed when psoriasis, cutaneous lymphoma, or atypical eruptions are in the differential.

Treatment Options

Treatment aims to reduce inflammation, relieve itching, repair the skin barrier, and prevent flare‑ups. Therapy is individualized based on severity (mild, moderate, severe) and patient age.

Topical Medications

• Corticosteroids – First‑line; low‑potency (hydrocortisone 1%) for mild disease, medium‑potency (triamcinolone 0.1%) for moderate disease, and high‑potency (clobetasol propionate 0.05%) for severe patches. Use as short as possible to limit skin thinning.
• Topical calcineurin inhibitors (TCIs) – Tacrolimus 0.03–0.1% and pimecrolimus 1%; useful on the face and neck to avoid steroid side effects.
• Phosphodiesterase‑4 inhibitor – Crisaborole 2% ointment (Eucrisa) approved for mild‑to‑moderate eczema.
• Barrier repair creams – Moisturizers containing ceramides, cholesterol, and fatty acids (e.g., CeraVe, EpiCeram).

Systemic Therapies

• Oral antihistamines – Helpful for night‑time itch, though evidence of efficacy is modest.
• Systemic corticosteroids – Short courses for severe acute flares; not recommended for long‑term use due to side effects.
• Immunomodulators – Methotrexate, azathioprine, or cyclosporine for refractory disease.
• Biologic agents – Dupilumab (IL‑4Rα antagonist) is FDA‑approved for moderate‑to‑severe atopic dermatitis in adults and adolescents 12 years and older. Recent trials also support tralokinumab and lebrikizumab.

Procedural Interventions

• Phototherapy (NB‑UVB) – Effective for moderate disease unresponsive to topicals.
• Wet wrap therapy – Application of a topical steroid/moisturizer followed by a damp cloth and dry layer; accelerates healing during severe flares.

Lifestyle & Self‑Care

• Regular, liberal use of moisturizers (twice daily, after bathing).
• Avoidance of known irritants (fragrance, harsh soaps, wool).
• Use of lukewarm water baths limited to 5‑10 minutes.
• Keeping fingernails short to reduce skin trauma from scratching.
• Stress‑reduction techniques (mindfulness, yoga, CBT).

Living with Skin Eczema

Managing eczema is a daily commitment. Below are practical tips that improve quality of life.

• Moisturize while skin is still damp – Pat skin dry, then apply an ointment‑based moisturizer within three minutes to lock in water.
• Choose gentle skin‑care products – Look for “fragrance‑free,” “dye‑free,” and “hypoallergenic” labels. Syndet (synthetic detergent) cleansers are less irritating than traditional soaps.
• Dress in breathable fabrics – Cotton, silk, or bamboo are best; avoid wool, polyester, and tight clothing that trap heat.
• Maintain a cool, humid environment – Aim for indoor humidity 40‑60 % and temperature 20‑22 °C (68‑72 °F).
• Keep a symptom diary – Record flare‑up triggers, medication use, and stress levels to identify patterns.
• Family and school support – Educate caregivers and teachers about the condition to prevent bullying and ensure prompt treatment.
• Nutrition considerations – While evidence is mixed, some patients benefit from eliminating confirmed food allergens; consider a referral to an allergist before dietary restriction.

Prevention

Although eczema cannot be completely prevented, the following strategies can reduce the frequency and severity of flare‑ups:

• **Barrier‑focused skin care** – Apply moisturizers at least twice daily, especially after showers.
• **Avoid known irritants** – Use fragrance‑free detergents, soft‑water washing, and avoid prolonged exposure to hot water.
• **Control indoor allergens** – Wash bedding in hot water weekly, use dust‑mite‑proof covers, and keep pets out of the bedroom.
• **Prompt treatment of infections** – Early use of topical antibiotics for secondary bacterial infection reduces chronic inflammation.
• **Stress management** – Regular exercise, meditation, and adequate sleep have been shown to lower itch intensity.

Complications

If eczema remains uncontrolled, several complications can arise:

• Skin infections – Bacterial (Staphylococcus aureus, Streptococcus) and viral (eczema herpeticum) infections are common.
• Chronic lichenification – Thickened skin can become painful and less responsive to treatment.
• Psychosocial impact – Higher rates of anxiety, depression, and low self‑esteem, especially in adolescents.
• Sleep disturbance – Persistent itching can lead to chronic sleep deprivation.
• Potential development of other atopic diseases – Children with eczema are at increased risk for asthma and allergic rhinitis (“atopic march”).

When to Seek Emergency Care

References

1. World Health Organization. "Global Report on Atopic Dermatitis." 2022.
2. Centers for Disease Control and Prevention. "Prevalence of Eczema Among Children, United States, 2017‑2019." 2021.
3. National Institute of Allergy and Infectious Diseases. "Atopic Dermatitis Overview." 2023.
4. Mayo Clinic. "Atopic dermatitis (eczema) treatment." Updated 2024.
5. Cleveland Clinic. "Eczema: Symptoms, Diagnosis, and Management." 2023.
6. American Academy of Dermatology. "Guidelines of Care for the Management of Atopic Dermatitis." 2023.

```